Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem + Antidepressant for Secondary Insomnia in Depression
NCT00292734Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zolpidem in Insomnia (2 arms), sponsored by Sanofi. Primary endpoint: Efficacy of the combination of Stilnox + antidepressant therapy in the treatment of secondary insomnia. Started Jan 2005; status: completed.
02
Drugs
zolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00292734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292734.